• Proceedings of the Korean Society of Plant Biotechnology Conference
• /
• 2004.10a
• /
• pp.123-123
• /
• 2004

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 2000.04a
• /
• pp.1-2
• /
• 2000

일반적인 신약 개발 방법으로는 천연물로부터 선도화합물이 발견되었을 때 의약화학자들은 그 물질의 화학구조식 중에서 약리 작용에 필수 요건이 되는 구조 요소를 규정하고, 체계적인 분자변형을 통하여 약리 작용의 최적화 작업을 추진한다. 그러나 분자 내에 여러 가지 치환기를 도입할 수 있는 경우 수많은 유도체가 합성 가능하며, 실제로 이와 같은 많은 수의 유도체를 합성한다는 것은 현실적으로 불가능하다. 통계적으로 하나의 신약 개발에 드는 시간과 경비는 약 10년 이상의 기간과 3,000 억원 이상의 경비가 소요된다. 따라서 시간과 경비를 줄이는 노력의 하나로 실험분야에서는 조합 화학합성 (Combinatorial Chemical Synthesis, CCS) 기술인 새로운 개념의 고효율 합성 기술이나 이를 대량 검색할 수 있는 초고속 활성 검색법 (High Through-put Screening, HTS) 기술이 1990년대 초에 본격적으로 각광 받게되었고, 정보관리 시스템을 통한 library 구축, 컴퓨터를 이용한 구조-활성 관계 및 분자 설계 기법이 급속히 발전하게 되었다. 따라서 기존의 random screening에 의한 신약개발 방법으로부터 탈피하여 새로운 차원의 신의약 개발 방법의 필요성이 절실히 요구되고 있다.

• Asian Pacific Journal of Cancer Prevention
• /
• v.17 no.4
• /
• pp.2291-2295
• /
• 2016

Small molecule tyrosine kinase inhibitors targeting HER 2 receptors have emerged as an important therapeutic approach in inhibition of downstream proliferation and survival signals for the treatment of breast cancers. Recent drug discovery efforts have demonstrated that naturally occurring polyphenolic compounds like delphinidin have potential to inhibit proliferation and promote apoptosis of breast cancer cells by targeting HER2 receptors. While delphinidin may thus reduce tumour size, it is associated with serious side effects like dysphonia. Owing to the narrow therapeutic window of delphinidin, the present study aimed to identify high affinity compounds targeting HER2 with safer pharmacological profiles than delphinidin through virtual screening approaches. Delphinidin served as the query parent for identification of structurally similar compounds by Tanimoto-based similarity searching with a threshold of 95% against the PubChem database. The compounds retrieved were further subjected to Lipinski and Verber's filters to obtain drug like agents, then further filtered by diversity based screens with a cut off of 0.6. The compound with Pubchem ID: 91596862 was identified to have higher affinity than its parent. In addition it also proved to be non-toxic with a better ADMET profile and higher kinase activity. The compound identified in the study can be put to further in vitro drug testing to complement the present study.

• Microbiology and Biotechnology Letters
• /
• v.34 no.1
• /
• pp.58-62
• /
• 2006

Rapid assay of enzyme is a primary requirement for successful application of directed evolution technology. Halo generation on a turbid plate would be a method of choice for high throughput screening of enzymes in this context. Here we report a new approach to prepare turbid plates, by controlling the crystallization of tyrosine to form needle-like particles. In the presence of tyrosine phenol-lyase (TPL), the needle-like tyrosine crystals were converted to soluble phenol rapidly than the usual rectangular tyrosine crystals. When an error-prone PCR library of Citrobacter freundii TPL was spread on the turbid plate, approximately 10% of the colonies displayed recognizable halos after 24 hours of incubation at $37^{\circ}C$. Representative positives from the turbid plates were transferred to LB-medium in 96-wellplates, cultivated overnight, and assayed for the enzyme activity with L-tyrosine as the substrate. The assay results were approximated to be proportional to the halo size on turbid plates, suggesting the screening system is directly applicable to the directed evolution of TPL. Actually, two best mutants on the turbid plates were identified to be $2{\sim}2.5$ and 1.5-fold improved in the activity.